Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

Kanwal, Fasiha; R. Kramer, Jennifer; M. Asch, Steven; Chayanupatkul, Maneerat; Cao, Yumei; B. El‐Serag, Hashem

doi:10.1053/j.gastro.2017.06.012

Public

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

Published in Gastroenterology • Jun 20, 2017

Authors:

Fasiha Kanwal

Jennifer R. Kramer

Steven M. Asch

Abstract

BACKGROUND AND AIMS: The risk of hepatocellular cancer (HCC) after sustained virological response (SVR) with direct-acting antivirals (DAA) is unclear. Our aim was to examine the risk and determinants of HCC in patients cured with DAA. METHODS: We conducted a retrospective cohort study of hepatitis ...

Subject

Medicine

Internal medicine

Hazard ratio

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!